{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Two participants in a discontinued clinical drug trial have sued Amgen, demanding that it resume giving them an experimental treatment for Parkinson's disease that they say helped them immensely but that the company says is ineffective and potentially dangerous. In their lawsuit, filed yesterday in Federal District Court in Manhattan, the plaintiffs say Amgen ''treated the patients as mere guinea pigs, as material to be discarded,'' and had violated a legal and moral obligation to continue to supply the drug.", "headline": {"main": "Parkinson's Patients Suing Amgen Over Drug"}, "abstract": "Robert Suthers and Niwana Martin, participants in discontinued clinical drug trial, sue Amgen, demanding that it resume giving them experimental treatment--glial cell line-derived neurotrophic factor, or GDNF--for Parkinson's disease that they say helped them immensely but company says it is ineffective and potentially dangerous; plaintiffs say Amgen treated patients as mere guinea pigs, as material to be discarded, and have violated legal and moral obligation to continue to supply drug; Amgen declines comment; photo (M)", "print_page": "2", "word_count": 526, "_id": "4fd283a98eb7c8105d85245c", "snippet": "Two participants in a discontinued clinical drug trial have sued Amgen, demanding that it resume giving them an experimental treatment for Parkinson's disease.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/04/27/business/27amgen.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SUTHERS, ROBERT"}, {"name": "persons", "value": "MARTIN, NIWANA"}, {"name": "organizations", "value": "AMGEN INCORPORATED"}, {"name": "organizations", "value": "AMGEN INC"}, {"name": "subject", "value": "GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "PARKINSON'S DISEASE"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2005-04-27T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Johnson & Johnson has added data about deaths to the package insert of its heart-failure treatment Natrecor after studies in two medical journals raised questions about an increased risk of fatal kidney problems in those treated with the drug. The label change, which stops short of a warning, was approved last week by the Food and Drug Administration. It reports that in clinical trials 5.3 percent of the patients treated with Natrecor died, compared with 4.3 percent in control groups. But the new label notes that the data might not be statistically significant because of the small numbers of patients involved.", "headline": {"main": "Johnson & Johnson Adds Data on Deaths to Label on Heart Treatment"}, "abstract": null, "print_page": "4", "word_count": 632, "_id": "4fd2460e8eb7c8105d7e11e9", "snippet": "Johnson & Johnson has added data about deaths to the package insert of its heart-failure treatment Natrecor after studies in two medical journals raised questions about an increased risk of fatal kidney problems in those treated with the drug.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/04/26/health/26drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "HEART"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "TESTS AND TESTING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Stephanie", "rank": 1, "lastname": "SAUL"}], "original": "By STEPHANIE SAUL"}, "document_type": "article", "pub_date": "2005-04-26T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 2, "offset": 0, "time": 29}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}